519 related articles for article (PubMed ID: 1717137)
21. Expression of developmentally regulated muscle proteins in rhabdomyosarcomas.
Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Barbet JP; Butler-Browne GS; Meijer CJ
Am J Pathol; 1994 Oct; 145(4):895-901. PubMed ID: 7524332
[TBL] [Abstract][Full Text] [Related]
22. All histological types of primary human rhabdomyosarcoma express alpha-cardiac and not alpha-skeletal actin messenger RNA.
Schürch W; Bochaton-Piallat ML; Geinoz A; d'Amore E; Laurini RN; Cintorino M; Bégin LR; Boivin Y; Gabbiani G
Am J Pathol; 1994 Apr; 144(4):836-46. PubMed ID: 8160781
[TBL] [Abstract][Full Text] [Related]
23. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
[TBL] [Abstract][Full Text] [Related]
25. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
Haider SR; Wang W; Kaufman SJ
Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
[TBL] [Abstract][Full Text] [Related]
26. Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis.
Montarras D; Chelly J; Bober E; Arnold H; Ott MO; Gros F; Pinset C
New Biol; 1991 Jun; 3(6):592-600. PubMed ID: 1911647
[TBL] [Abstract][Full Text] [Related]
27. The expression pattern of contractile and intermediate filament proteins in developing skeletal muscle and rhabdomyosarcoma of childhood: diagnostic and prognostic utility.
Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Voute PA; Meijer CJ
J Pathol; 1994 Dec; 174(4):283-92. PubMed ID: 7884590
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility.
Dias P; Parham DM; Shapiro DN; Tapscott SJ; Houghton PJ
Cancer Res; 1992 Dec; 52(23):6431-9. PubMed ID: 1384962
[TBL] [Abstract][Full Text] [Related]
29. Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development.
Hinterberger TJ; Sassoon DA; Rhodes SJ; Konieczny SF
Dev Biol; 1991 Sep; 147(1):144-56. PubMed ID: 1715299
[TBL] [Abstract][Full Text] [Related]
30. Dexamethasone-mediated induction of MMTV-myf5 in DD3 myoblasts increases endogenous myogenin expression but does not transactivate myf5.
Arnold TE; Worrell RA; Barth JL; Morris J; Ivarie R
Exp Cell Res; 1994 Jun; 212(2):321-8. PubMed ID: 8187825
[TBL] [Abstract][Full Text] [Related]
31. Neural and hormonal control of expression of myogenic regulatory factor genes during regeneration of Xenopus fast muscles: myogenin and MRF4 mRNA accumulation are neurally regulated oppositely.
Nicolas N; Mira JC; Gallien CL; Chanoine C
Dev Dyn; 2000 May; 218(1):112-22. PubMed ID: 10822264
[TBL] [Abstract][Full Text] [Related]
32. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.
Kumar S; Perlman E; Harris CA; Raffeld M; Tsokos M
Mod Pathol; 2000 Sep; 13(9):988-93. PubMed ID: 11007039
[TBL] [Abstract][Full Text] [Related]
33. A new marker for rhabdomyosarcoma. Insulin-like growth factor II.
Yun K
Lab Invest; 1992 Nov; 67(5):653-64. PubMed ID: 1434543
[TBL] [Abstract][Full Text] [Related]
34. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
Sirri V; Leibovitch MP; Leibovitch SA
Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
[TBL] [Abstract][Full Text] [Related]
35. [Early stages of myogenesis as seen through the action of the myf-5 gene].
Buckingham M
C R Seances Soc Biol Fil; 1997; 191(1):43-54. PubMed ID: 9181127
[TBL] [Abstract][Full Text] [Related]
36. Involvement of myogenic regulator factors during fusion in the cell line C2C12.
Dedieu S; Mazères G; Cottin P; Brustis JJ
Int J Dev Biol; 2002 Mar; 46(2):235-41. PubMed ID: 11934152
[TBL] [Abstract][Full Text] [Related]
37. Muscle-specific transcription factors in fibroblasts expressing the alpha-striated tropomyosin 3' untranslated region.
L'ecuyer TJ; Schutte BC; Mendel KA; Morris E; Fulton AB
Mol Genet Metab; 1999 Jul; 67(3):213-26. PubMed ID: 10381329
[TBL] [Abstract][Full Text] [Related]
38. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
39. Myf5, MyoD, myogenin and MRF4 myogenic derivatives of the embryonic mesenchymal cell line C3H10T1/2 exhibit the same adult muscle phenotype.
Auradé F; Pinset C; Chafey P; Gros F; Montarras D
Differentiation; 1994 Feb; 55(3):185-92. PubMed ID: 8187980
[TBL] [Abstract][Full Text] [Related]
40. A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
Gattenloehner S; Dockhorn-Dworniczak B; Leuschner I; Vincent A; Müller-Hermelink HK; Marx A
J Mol Diagn; 1999 Nov; 1(1):23-31. PubMed ID: 11272905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
